Tirzepatide at 5, 10, and 15 mg weekly produced superior HbA1c reductions compared to both placebo and active comparators including semaglutide
Learn more about how CVS Caremark makes drugs more affordable for members: #TeamCVS To view or add a comment, sign in Lowering specialty drug costs is essential to improving member outcomes
The researchers found that in trial 1, the mean change in AHI was 25.3 and 5.3 events per hour with tirzepatide and placebo, respectively, at week 52 (estimated treatment difference, 20.0 events per hour)
If avoiding injections is a priority, Oral Wegovy or Foundayo are both daily tablet options that are FDA-approved, clinically validated, and available through Klinic with insurance coverage
Tirzepatide should not be considered a treatment or preventive therapy for Alzheimer's disease based on current evidence
Evidence-based medical solutionssuch as GLP-1 peptide therapy (Tirzepatide) offer safe, effective options to support long-term weight loss and metabolic improvement